Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/106034
Full metadata record
DC FieldValueLanguage
dc.contributor.CRUESPUNIVERSIDADE DE ESTADUAL DE CAMPINASpt_BR
dc.typeArtigo de periódicopt_BR
dc.titleShort Stature In Chronic Kidney Disease: Physiopathology And Treatment With Growth Hormone [baixa Estatura Na Doença Renal Crônica: Fisiopatologia E Tratamento Com Hormônio De Crescimento]pt_BR
dc.contributor.authorDe Oliveira J.C.pt_BR
dc.contributor.authorSiviero-Miachon A.A.pt_BR
dc.contributor.authorSpinola-Castro A.M.pt_BR
dc.contributor.authorBelangero V.M.S.pt_BR
dc.contributor.authorGuerra Jr. G.pt_BR
unicamp.authorDe Oliveira, J.C., Clínica Médica, Faculdade de Ciências Médicas (FCM), Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazilpt_BR
unicamp.authorBelangero, V.M.S., Unidade de Nefrologia Pediátrica, Departamento de Pediatria, FCM-Unicamp, Campinas, SP, Brazilpt_BR
unicamp.authorGuerra Jr., G., Unidade de Endocrinologia Pediátrica, Departamento de Pediatria, FCM-Unicamp, Campinas, SP, Brazil, Departamento de Pediatria, Faculdade de Ciências Médicas, Unicamp, CP 6111, 13083-970 Campinas, SP, Brazilpt_BR
unicamp.author.externalSiviero-Miachon, A.A., Programa de Pós-graduação do Curso de Pediatria, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazilpt
unicamp.author.externalSpinola-Castro, A.M., Unidade de Endocrinologia Pediátrica, Departamento de Pediatria, EPM-Unifesp, São Paulo, SP, Brazilpt
dc.description.abstractGrowth failure is frequent and a clinically important issue in children with chronic kidney disease (CKD). Many factors contribute to impaired growth in these children, including abnormalities in the growth hormone (GH) - insulin-like growth factor 1 (IGF-1) axis, malnutrition, acidosis, renal bone disease and glucocorticoid associated treatment. The management of growth failure in children with CKD is complicated by the presence of other-disease related complications requiring medical intervention. Despite evidence of GH efficacy and safety in this population, this therapy is still underutilized. This review shows the impact, the causes and the treatment of growth failure in children with CKD. copyright© ABE&M todos os direitos reservados.en
dc.relation.ispartofArquivos Brasileiros de Endocrinologia e Metabologiapt_BR
dc.date.issued2008pt_BR
dc.identifier.citationArquivos Brasileiros De Endocrinologia E Metabologia. , v. 52, n. 5, p. 783 - 791, 2008.pt_BR
dc.language.isoptpt_BR
dc.description.volume52pt_BR
dc.description.issuenumber5pt_BR
dc.description.firstpage783pt_BR
dc.description.lastpage791pt_BR
dc.rightsabertopt_BR
dc.sourceScopuspt_BR
dc.identifier.issn42730pt_BR
dc.identifier.urlhttp://www.scopus.com/inward/record.url?eid=2-s2.0-51949094002&partnerID=40&md5=1888960b78091b762d554dd937c1aa4apt_BR
dc.date.available2015-06-30T19:23:27Z
dc.date.available2015-11-26T15:42:28Z-
dc.date.accessioned2015-06-30T19:23:27Z
dc.date.accessioned2015-11-26T15:42:28Z-
dc.description.provenanceMade available in DSpace on 2015-06-30T19:23:27Z (GMT). No. of bitstreams: 1 2-s2.0-51949094002.pdf: 477986 bytes, checksum: 585ad2672539b8121ac69eb0018ba360 (MD5) Previous issue date: 2008en
dc.description.provenanceMade available in DSpace on 2015-11-26T15:42:28Z (GMT). No. of bitstreams: 2 2-s2.0-51949094002.pdf: 477986 bytes, checksum: 585ad2672539b8121ac69eb0018ba360 (MD5) 2-s2.0-51949094002.pdf.txt: 39403 bytes, checksum: 047d80b5cb474f7fd18c2e8e5e7d61d7 (MD5) Previous issue date: 2008en
dc.identifier.urihttp://www.repositorio.unicamp.br/handle/REPOSIP/106034
dc.identifier.urihttp://repositorio.unicamp.br/jspui/handle/REPOSIP/106034-
dc.identifier.idScopus2-s2.0-51949094002pt_BR
dc.description.referenceK/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification (2002) Am J Kidney Dis, 39 (2 SUPPL. 1), pp. S1-266. , National Kidney Foundationpt_BR
dc.description.referenceChesney, R.W., Brewer, E., Moxey-Mims, M., Watkins, S., Furth, S.L., Harmon, W.E., Report of NIH task force on research priorities in chronic kidney disease in children (2006) Pediatr Nephrol, 21, pp. 14-25pt_BR
dc.description.referenceNAPRTCS Annual Report, , https://web.emmes.com/study/ped/annlrept/annlrept2005.pdf, acesso em 2005, Disponível empt_BR
dc.description.referenceSeikaly, M.G., Salhab, N., Warandy, B.A., Stablein, D., Use o hrGH in children with chronic kidney disease: Lessons from NAPRTCS (2007) Pediatr Nephrol, 22, pp. 1195-1204pt_BR
dc.description.referenceMahesh, S., Kaskel, F., Growth hormone axis in chronic kidney disease (2008) Pediatr Nephrol, 23, pp. 41-48pt_BR
dc.description.referenceGorman, G., Frankenfield, D., Linear growth in pediatric hemodialysis patients (2008) Pediatr Nephrol, 23, pp. 123-127pt_BR
dc.description.referenceUlinski, T., Cochat, P., Longitudinal growth in children following kidney transplantation: From conservative to pharmacological strategies (2006) Pediatr Nephrol, 21, pp. 903-909pt_BR
dc.description.referenceVimalanchandra, D., Hodson, E.M., Willis, N.S., Craig, J.C., Cowell, C., Knight, J.F., Growth hormone for children with chronic kidney disease (Cochrane Review) (2006) Cochrane Database Syst Rev, 19. , CD003264pt_BR
dc.description.referenceWilliams, R., Growth hormone underutilized in pediatric hemodialysis population (2006) Nat Clin Pract Nephrol, p. 2. , Disponível em: doi:10.1038/ncpneph0081pt_BR
dc.description.referenceMahan, J.D., Warady, B.A., Assessment and treatment of short stature in pediatric patients with chronic kidney disease: A consensus statement (2006) Pediatr Nephrol, 21, pp. 917-930pt_BR
dc.description.referenceLewis, M., Shaw, J., Reid, C., Evans, J., Webb, N., Verrier-Jones, K., Growth in children with established renal failure: A registry analysis (2007) Nephrol Dial Transplant, 22, pp. 76-180pt_BR
dc.description.referenceTom, A., McCauley, L., Bell, L., Rodd, C., Espinosa, P., Yu, G., Growth during maintenance hemodialysis: Impact of enhanced nutrition and clearance (1999) J Pediatr, 134, pp. 464-471pt_BR
dc.description.referenceRoth, K.S., Duncan, L.L., Chan, J.C., The role of nutrition in chronic renal insufficiency of childhood: How much do we know? (2005) Crit Rev Food Sci Nutr, 45, pp. 259-263pt_BR
dc.description.referenceJarkovská, Z., Hodková, M., Sazamová, M., Rosická, M., Dusilová-Sulková, S., Marek, J., Plasma levels of active and total ghrelin in renal failure: A relationship with GH/IGF-1 axis (2005) Growth Horm IGF Res, 15, pp. 369-376pt_BR
dc.description.referenceMak, R.H., Cheung, W., Cone, R.D., Marks, D.L., Orexygenic and anorexygenic mechanisms in the control of nutrition in chronic kidney disease (2005) Pediatr Nephrol, 20, pp. 427-431pt_BR
dc.description.referenceRees, L., Shaw, W., Nutrition in children with CRF and on dialysis (2007) Pediatr Nephrol, 22, pp. 1689-1702pt_BR
dc.description.referenceGraf, L., Candelaria, S., Doyle, M., Kaskel, F., Nutrition assessment and hormonal influences on body composition in children with chronic kidney disease (2007) Adv Chronic Kidney Dis, 14, pp. 215-223pt_BR
dc.description.referenceUauy, R.D., Hogg, R.J., Brewer, E.D., Reisch, J.S., Cunningham, C., Holliday, M.A., Dietary and growth in infants with chronic renal insufficiency: A report from the Southwest Pediatric Nephrology Study Group and the University of California, San Francisco (1994) Pediatr Nephrol, 8, pp. 45-50pt_BR
dc.description.referenceLane, P.H., Puberty and chronic kidney disease (2005) Adv Chronic Kidney Dis, 12, pp. 372-377pt_BR
dc.description.referenceHokken-Koelega, A.C., Saenger, P., Cappa, M., Greggio, N., International Workshop on Management of Puberty for Optimum Auxological Results. Unresolved problems concerning optimal therapy of puberty in children with chronic renal diseases (2001) J Pediatr Endocrinol Metab, 14 (SUPPL. 2), pp. 945-952pt_BR
dc.description.referenceLangman, C.B., Renal osteodystrophy: A pediatric perspective, 2005 (2005) Growth Horm IGF Res, 15 (SUPPL. A), pp. 42-47pt_BR
dc.description.referenceSantos, F., Carbajo-Pérez, E., Rodríguez, J., Fernández-Fuente, M., Molinos, I., Amil, B., Alterations of the growth plate in chronic renal failure (2005) Pediatr Nephrol, 20, pp. 330-334pt_BR
dc.description.referenceRabkin, R., Sun, D.F., Chen, Y., Tan, J., Shaefer, F., Growth hormone resistance in uremia: A role of impaired JAK/STAT signaling (2005) Pediatr Nephrol, 20, pp. 313-318pt_BR
dc.description.referenceRoelfsema, V., Clark, R.G., The growth hormone and insulin-like growth factor axis: Its manipulation for the benefit of growth disorders in renal failure (2001) J Am Soc Nephrol, 12, pp. 1297-1306pt_BR
dc.description.referenceTonshoff, B., Kiepe, D., Ciarmatori, S., Growth hormone/insulin-like growth factor system in children with chronic renal failure (2005) Pediatr Nephrol, 20, pp. 279-289pt_BR
dc.description.referenceSmink, J.J., Buchholz, I.M., Hamers, N., van Tilburg, C.M., Christis, C., Sakkers, R.J., Short-term glucocorticoid treatment of piglets causes changes in growth plate morphology and angiogenesis (2003) Osteoarthritis Cartilage, 11, pp. 864-871pt_BR
dc.description.referenceJux, C., Leiber, K., Hügel, U., Blum, W., Ohlsson, C., Klaus, G., Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes (1998) Endocrinology, 139, pp. 3296-3305pt_BR
dc.description.referenceKlaus, G., Jux, C., Fernandez, P., Rodriguez, J., Himmele, R., Mehls, O., Suppression of growth plate chondrocyte proliferation by corticosteroids (2000) Pediatr Nephrol, 14, pp. 612-615pt_BR
dc.description.referenceKoedam, J.A., Hoogerbrugge, C.M., van Buul-Offers, S.C., Differential regulation of IGF-binding proteins in rabbit costal chondrocytes by IGF-I and dexamethasone (2000) J Endocrinol, 165, pp. 557-567pt_BR
dc.description.referenceSmink, J.J., Koedam, J.A., Koster, J.G., van Buul-Offers, S.C., Dexamethasone-induced growth inhibition of porcine growth plate chondrocytes is accompanied by changes in levels of IGF axis components (2002) J Endocrinol, 174, pp. 343-352pt_BR
dc.description.referenceOliveira, J.C., Machado Neto, F.A., Morcilo, A.M., Oliveira, L.C., Belangero, V.M.S., Gelonese Neto, B., Insuficiência renal crônica e hormônio de crescimento: Efeitos no eixo GH-IGFe na leptina. (2005) Arq Bras Endocrinol Metab, 49, pp. 964-970pt_BR
dc.description.referenceMehls, O., Himmele, R., Hömme, M., Kiepe, D., Klaus, G., The interaction of glucocorticoids with the growth hormone-insulin-like growth factor axis and its effects on growth plate chondrocytes and bone cells (2001) J Pediatr Endocrinol Metab, 14 (SUPPL. 6), pp. 1475-1482pt_BR
dc.description.referenceJonsson, K.B., Ljunghall, S., Karlström, O., Johansson, A.G., Mallmin, H., Ljunggren, O., Insulin-like growth factor I enhances the formation of type I collagen in hydrocortisone-treated human osteoblasts (1993) Biosci Rep, 13, pp. 297-302pt_BR
dc.description.referenceKlare, B., Strom, T.M., Hahn, H., Engelsberger, I., Meusel, E., Illner, W.D., Remarkable long-term prognosis and excellent growth in kidney-transplant children under cyclosporine monotherapy (1991) Transplant Proc, 23, pp. 1013-1017pt_BR
dc.description.referenceShampiro, R., Scantlebury, V.P., Jordan, M.L., Vivas, C., Ellis, D., Lombardozzi-Lane, S., Pediatric renal transplantation under tacrolimus-based immunosuppression (1999) Transplantation, 67, pp. 299-303pt_BR
dc.description.referenceMehls, O., Ritz, E., Skeletal growth in experimental uremia (1983) Kidney Int, 21 (SUPPL.), pp. 53-62pt_BR
dc.description.referenceHaffner, D., Schaefer, F., Does recombinant growth hormone improve adult height in children with chronic renal failure? (2001) Semin Nephrol, 21, pp. 490-497pt_BR
dc.description.referenceFine, R.N., Stablein, D., Long-term use of recombinant growth hormone in pediatric allograft recipients: A report from the NAPTRCS Transplant Registry (2005) Pediatr Nephrol, 20, pp. 404-408pt_BR
dc.description.referenceCrompton, C.H., Australian and New Zeland Paediatric Nephrology Association. Long-term recombinant human growth hormone use in Australian children with renal disease (2004) Nephrology (Carlton), 9, pp. 325-330pt_BR
dc.description.referenceAndre, J.L., Bourquard, R., Guillemin, F., Krier, M.J., Briancon, S., Final height in children with chronic renal failure who have not received growth hormone (2003) Pediatr Nephrol, 18, pp. 685-689pt_BR
dc.description.referenceMehls, O., Lindberg, A., Nissel, R., Wühl, E., Schaefer, F., Tönshoff, B., Growth hormone treatment in short children with chronic kidney disease (2007) Growth hormone therapy in pediatrics, pp. 407-421. , Ranke MB, Price DA, Reiter EO, editores, Basel: Karger;pt_BR
dc.description.referenceGuest, G., Berard, E., Crosnier, H., Chevallier, T., Rappaport, R., Broyer, M., Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology (1998) Pediatr Nephrol, 12, pp. 437-446pt_BR
dc.description.referenceFine, R.N., Ho, M., Tejani, A., Blethen, S., Adverse events with hrGH treatment of patients with chronic renal insufficiency and end-stage renal disease (2003) J Pediatr, 142, pp. 539-545pt_BR
dc.description.referenceFine, R.N., Stablein, D., Cohen, A.H., Tejani, A., Kohaut, E., Recombinant human growth hormone post-renal transplantation in children: A randomized controlled study of the NAPRTCS (2002) Kidney Int, 62, pp. 688-696pt_BR
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
2-s2.0-51949094002.pdf466.78 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.